Attachment 5 Required Tests and Pricing.xlsx
XLSX spreadsheet 29 KB Posted
- Attached to
- Wet Chemistry and Immunoassay Platform Lease and Cost-Per-Reportable-Result (CPRR) Testing Services
- Solicitation number
- HT940625QE010
- Issued by
-
Defense Health Agency
About this file
This is an Excel-based pricing attachment for a Request for Quotation (RFQ) HT940625QE010 for Wet Chemistry and Immunology Platform Lease and Clinical Reagents and Consumables services. The document details a comprehensive pricing schedule covering multiple chemistry tests across a base period and five option periods from June 2026 to December 2031, with varying annual usage volumes for 25 different clinical chemistry tests including albumin, creatinine, glucose, cholesterol, and thyroid-related tests. The contract is structured with a 4-month base period followed by five option periods, with the final option period including two additional extension periods under FAR 52.217-8, supporting the 6th Medical Group at MacDill Air Force Base in Florida. While the unit prices are currently listed as zero, the document provides a detailed breakdown of anticipated test volumes for each period, suggesting a cost-per-reportable-result (CPRR) pricing model for clinical laboratory services.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Base Period
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| * Base Period: (4 June 2026 - 30 September 2026) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 5,333 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 5,333 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 5,666 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 5,666 | $ - 0 | $ - 0 |
| Calcium (CA) | 5,666 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 3,733 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 666 | $ - 0 | $ - 0 |
| Magnesium (MG) | 333 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 333 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 333 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 6,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 333 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 264 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 366 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 5,333 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 5,333 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 666 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 5,333 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 4,333 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 6,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 4,333 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 5,666 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 6,000 | $ - 0 | $ - 0 |
| Potassium (K) | 4,333 | $ - 0 | $ - 0 |
| Sodium (NA) | 4,333 | $ - 0 | $ - 0 |
| Total Protein (TP) | 5,333 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 1,466 | $ - 0 | $ - 0 |
| TOTAL BASE PERIOD: | $ - 0 | ||
| * Base period will have a PoP of 4-months. |
Option 1
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| Option Period 1: (1 October 2026 - 30 September 2027) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 16,000 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 16,000 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 17,000 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 17,000 | $ - 0 | $ - 0 |
| Calcium (CA) | 17,000 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 11,200 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 2,000 | $ - 0 | $ - 0 |
| Magnesium (MG) | 1,000 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 1,000 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 1,000 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 18,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 3,700 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 12,700 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 1,100 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 16,000 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 16,000 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 2,000 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 16,000 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 13,000 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 18,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 13,000 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 17,000 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 18,000 | $ - 0 | $ - 0 |
| Potassium (K) | 13,000 | $ - 0 | $ - 0 |
| Sodium (NA) | 13,000 | $ - 0 | $ - 0 |
| Total Protein (TP) | 16,000 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 4,400 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 1: | $ - 0 |
Option 2
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| Option Period 2: (1 October 2027 - 30 September 2028) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 16,000 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 16,000 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 17,000 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 17,000 | $ - 0 | $ - 0 |
| Calcium (CA) | 17,000 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 11,200 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 2,000 | $ - 0 | $ - 0 |
| Magnesium (MG) | 1,000 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 1,000 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 1,000 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 18,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 3,700 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 12,700 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 1,100 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 16,000 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 16,000 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 2,000 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 16,000 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 13,000 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 18,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 13,000 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 17,000 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 18,000 | $ - 0 | $ - 0 |
| Potassium (K) | 13,000 | $ - 0 | $ - 0 |
| Sodium (NA) | 13,000 | $ - 0 | $ - 0 |
| Total Protein (TP) | 16,000 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 4,400 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 2: | $ - 0 |
Option 3
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| Option Period 3: (1 October 2028 - 30 September 2029) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 16,000 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 16,000 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 17,000 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 17,000 | $ - 0 | $ - 0 |
| Calcium (CA) | 17,000 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 11,200 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 2,000 | $ - 0 | $ - 0 |
| Magnesium (MG) | 1,000 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 1,000 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 1,000 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 18,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 3,700 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 12,700 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 1,100 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 16,000 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 16,000 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 2,000 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 16,000 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 13,000 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 18,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 13,000 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 17,000 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 18,000 | $ - 0 | $ - 0 |
| Potassium (K) | 13,000 | $ - 0 | $ - 0 |
| Sodium (NA) | 13,000 | $ - 0 | $ - 0 |
| Total Protein (TP) | 16,000 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 4,400 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 3: | $ - 0 |
Option 4
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| Option Period 4: (1 October 2029 - 30 September 2030) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 16,000 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 16,000 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 17,000 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 17,000 | $ - 0 | $ - 0 |
| Calcium (CA) | 17,000 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 11,200 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 2,000 | $ - 0 | $ - 0 |
| Magnesium (MG) | 1,000 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 1,000 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 1,000 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 18,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 3,700 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 12,700 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 1,100 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 16,000 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 16,000 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 2,000 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 16,000 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 13,000 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 18,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 13,000 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 17,000 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 18,000 | $ - 0 | $ - 0 |
| Potassium (K) | 13,000 | $ - 0 | $ - 0 |
| Sodium (NA) | 13,000 | $ - 0 | $ - 0 |
| Total Protein (TP) | 16,000 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 4,400 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 4: | $ - 0 |
Option 5
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| * Option Period 5: (1 October 2030 - 3 June 2031) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 16,000 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 16,000 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 17,000 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 17,000 | $ - 0 | $ - 0 |
| Calcium (CA) | 17,000 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 11,200 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 2,000 | $ - 0 | $ - 0 |
| Magnesium (MG) | 1,000 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 1,000 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 1,000 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 18,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 3,700 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 12,700 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 1,100 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 16,000 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 16,000 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 2,000 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 16,000 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 13,000 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 18,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 13,000 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 17,000 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 18,000 | $ - 0 | $ - 0 |
| Potassium (K) | 13,000 | $ - 0 | $ - 0 |
| Sodium (NA) | 13,000 | $ - 0 | $ - 0 |
| Total Protein (TP) | 16,000 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 4,400 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 5: | $ - 0 | ||
| * Option 5 will have a PoP of 8-months. |
FAR 52.217-8 (4-Months)
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| * FAR 52.217-8 (4 June 2031 - 30 September 2031) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 5,333 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 5,333 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 5,666 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 5,666 | $ - 0 | $ - 0 |
| Calcium (CA) | 5,666 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 3,733 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 666 | $ - 0 | $ - 0 |
| Magnesium (MG) | 333 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 333 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 333 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 6,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 333 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 264 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 366 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 5,333 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 5,333 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 666 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 5,333 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 4,333 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 6,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 4,333 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 5,666 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 6,000 | $ - 0 | $ - 0 |
| Potassium (K) | 4,333 | $ - 0 | $ - 0 |
| Sodium (NA) | 4,333 | $ - 0 | $ - 0 |
| Total Protein (TP) | 5,333 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 1,466 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 5: | $ - 0 | ||
| * FAR 52.217-8, Option to Extend Services, for a PoP of 4-months. |
FAR 52.217-8 (2-Months)
| Request for Quotation (RFQ) HT940625QE010 | |||
| Wet Chemistry /Immunology Platform Lease & CPRR Clinical Reagents and Consumables | |||
| CHEMISTRY TEST | |||
| Period of Performance (PoP) | |||
| * FAR 52.217-8 (1 October 2031 - 3 December 2031) | ANNUAL USAGE | UNIT PRICE | AMOUNT |
| Albumin (ALB) | 2,666 | $ - 0 | $ - 0 |
| Alkaline Phosphatase (ALK/ALKP) | 2,666 | $ - 0 | $ - 0 |
| Creatinine (CREAT) | 2,833 | $ - 0 | $ - 0 |
| Blood Urea Nitrogen (BUN) | 2,833 | $ - 0 | $ - 0 |
| Calcium (CA) | 2,833 | $ - 0 | $ - 0 |
| Hemoglobin A1C (HbA1C) | 1,866 | $ - 0 | $ - 0 |
| High Sensitive C-Reactive Protein (HSCRP) | 333 | $ - 0 | $ - 0 |
| Magnesium (MG) | 166 | $ - 0 | $ - 0 |
| Phosphate (PHOS) | 166 | $ - 0 | $ - 0 |
| Gamma-Glutamyl Transferase (GGT) | 166 | $ - 0 | $ - 0 |
| Triglyceride (TRIG) | 3,000 | $ - 0 | $ - 0 |
| Free Thyroxine (FT4) | 616 | $ - 0 | $ - 0 |
| 3rd Generation Thyroid - Stimulating Hormore (TSH) | 2,116 | $ - 0 | $ - 0 |
| Alcohol/Ethanol (ALC/ETOH) | 183 | $ - 0 | $ - 0 |
| Alanine Aminotransferase (ALT) | 2,666 | $ - 0 | $ - 0 |
| Aspartate Aminotransferase (AST) | 2,666 | $ - 0 | $ - 0 |
| Direct Bilirubin (dBILI) | 333 | $ - 0 | $ - 0 |
| Total Bilirubin (TBILI) | 2,666 | $ - 0 | $ - 0 |
| Bicarbonate (ECO2) | 2,166 | $ - 0 | $ - 0 |
| Cholesterol (CHOL) | 3,000 | $ - 0 | $ - 0 |
| Chloride (CL) | 2,166 | $ - 0 | $ - 0 |
| Glucose (GLUC) | 2,833 | $ - 0 | $ - 0 |
| High Density Lipoprotein (HDL) | 3,000 | $ - 0 | $ - 0 |
| Potassium (K) | 2,166 | $ - 0 | $ - 0 |
| Sodium (NA) | 2,166 | $ - 0 | $ - 0 |
| Total Protein (TP) | 2,666 | $ - 0 | $ - 0 |
| Total Prostate-Specific Antigent (TPSA) | 733 | $ - 0 | $ - 0 |
| TOTAL OPTION PERIOD 5: | $ - 0 | ||
| * FAR 52.217-8, Option to Extend Services, for a PoP of 2-months. |
File details come from the government source that posted it. Updated .